Offstream
news

AstraZeneca-Oxford developers say that their vaccine candidate is effective against the UK variant of SARS-CoV-2.
2021-02-5

Kyrgyzstan is expected to receive 504,000 doses of the Oxford-AstraZeneca vaccine in March.
2021-02-2

Chile's health regulator approves a vaccine developed by the University of Oxford and AstraZeneca for emergency use in the country.
2021-01-27

India officially approves the emergency use of AstraZeneca and University of Oxford's AZD1222 vaccine, which is to be manufactured locally by the Serum Institute of India, as well as Bharat Biotech's BBV152 vaccine.
2021-01-3

The United Kingdom approves a vaccine made by the University of Oxford and AstraZeneca for use in the country. Health Secretary Matt Hancock says that the rollout of this vaccine will begin on January 4.
2020-12-30

Argentina approves a vaccine made by the University of Oxford and AstraZeneca for use in the country, becoming the second country after the UK to approve this vaccine.
2020-12-30

El Salvador approves a vaccine made by the University of Oxford and AstraZeneca for use in the country.
2020-12-30

AstraZeneca and University of Oxford's vaccine showed 90% efficacy when it was given to 2,741 people as a half-dose followed by a full dose and 62% efficacy when two full doses were given to 8,895 people.
2020-11-23

Phase III clinical trials for AstraZeneca and Oxford University's vaccine are paused after a participant suffers an illness requiring investigation in the United Kingdom.
2020-09-8

AstraZeneca begins Phase III clinical trials of its potential COVID-19 vaccine, AZD1222, which it developed with the University of Oxford, to some 30,000 adults in the United States.
2020-08-31